speb/financial-data huggingface dataset:
Financial ratios for CHS.V — quarterly report dated 2025-06-30
Total revenue: 1041535
Gross profit: 632922
Operating income: 12740
Net income: -69331
Capital expenditures: 186835
Operating cash flow: -207986
Depreciation & amortization: 25065
Net tangible assets: -5224009
Owner earnings: -231101
Capex to operating income (%): 1466.5227629513345
Buffett classification: The Gruesome
Stock price: 0.49635036496350365
Shares outstanding: 24948120
Book value: -5224009
Market cap (USD): 12383008.467153285
Debt to equity: -0.48279166440946025
Current ratio: 0.0789370511904053
Quick ratio: 0.0789370511904053
Interest coverage ratio: 0.1497607824236796
COGS to revenue (%): 39.23180690039221
R&D to revenue (%): 14.041678868208942
SG&A to revenue (%): 43.39662133293648
Free cash flow (dilution-adjusted): -394821
Buyback yield (%): 0
Retained earnings: -23425496
Receivables turnover: 3.2874141876430207
Capitalized R&D asset: 285885.5
Rosenberg metric: -0.37786886023586563
FCF margin (%): -37.907607521590734
Revenue growth (%): -0.3624713485962247
Rule of 40 score: -38.27007887018696
Financial ratios for CHS.V — quarterly report dated 2025-09-30
Total revenue: 1121911
Gross profit: 699685
Operating income: -121131
Net income: -175500
Capital expenditures: 6626
Operating cash flow: 175177
Depreciation & amortization: 31185
Net tangible assets: -5388566
Owner earnings: -150941
Buffett classification: The Gruesome
Stock price: 0.45323741007194246
Shares outstanding: 24948120
Book value: -5388566
Market cap (USD): 11307421.294964029
Debt to equity: -0.4598286445781679
Current ratio: 0.06370055889057515
Quick ratio: 0.06370055889057515
Interest coverage ratio: -1.797382517472141
COGS to revenue (%): 37.634625206455766
R&D to revenue (%): 11.658767941485555
SG&A to revenue (%): 59.50917675287969
Free cash flow (dilution-adjusted): 168551
Buyback yield (%): 0
Retained earnings: -23600995
Receivables turnover: 3.743246940436947
Capitalized R&D asset: 263569.5
Rosenberg metric: 0.45650226668216537
FCF margin (%): 15.023562475098293
Revenue growth (%): 7.717071437829742
Rule of 40 score: 22.740633912928036
Financial ratios for CHS.V — annual report dated 2025-12-31
Total revenue: 4120623
Gross profit: 2438017
Operating income: -1190095
Net income: -2144760
Capital expenditures: 173997
Operating cash flow: -711125
Depreciation & amortization: 110605
Net tangible assets: -6215142
Owner earnings: -2208152
Buffett classification: The Gruesome
Stock price: 0.40145985401459855
Shares outstanding: 24948120
Book value: -6215142
Market cap (USD): 10015668.613138687
Debt to equity: -0.43037053698853545
Current ratio: 0.06975807003838443
Quick ratio: 0.06975807003838443
Interest coverage ratio: -3.0295806020492586
COGS to revenue (%): 40.83377683423113
R&D to revenue (%): 18.385229612124185
SG&A to revenue (%): 66.97824576526413
Free cash flow (dilution-adjusted): -1134727
Buyback yield (%): 0
Retained earnings: -25657077
Receivables turnover: 11.044907378866139
Capitalized R&D asset: 1264549.2
Rosenberg metric: 0.7288060690874273
FCF margin (%): -27.537753393115555
Revenue growth (%): 9.324065539950048
Rule of 40 score: -18.213687853165506
Financial ratios for CHS.V — quarterly report dated 2025-12-31
Total revenue: 911852
Gross profit: 387661
Operating income: -1094056
Net income: -1744827
Capital expenditures: 22861
Operating cash flow: -113027
Depreciation & amortization: 45234
Net tangible assets: -6215142
Owner earnings: -1722454
Buffett classification: The Gruesome
Stock price: 0.40145985401459855
Shares outstanding: 24948120
Book value: -6215142
Market cap (USD): 10015668.613138687
Debt to equity: -0.43037053698853545
Current ratio: 0.06975807003838443
Quick ratio: 0.06975807003838443
Interest coverage ratio: -17.393577106518283
COGS to revenue (%): 58.795067620622646
R&D to revenue (%): 41.14011922987502
SG&A to revenue (%): 137.23345455183517
Free cash flow (dilution-adjusted): -318675
Buyback yield (%): 0
Retained earnings: -25657077
Receivables turnover: 2.4441257749699123
Capitalized R&D asset: 511035.83999999997
Rosenberg metric: -2.3854863494927407
FCF margin (%): -34.94810561363028
Revenue growth (%): -18.7233211903618
Rule of 40 score: -53.671426803992084
Financial ratios for COBH.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3395.102272727273
Shares outstanding: 75000
Market cap (USD): 254632670.45454547
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COBH.BR — annual report dated 2022-12-31
Total revenue: 119382978.72340426
Gross profit: 54405319.148936175
Operating income: 8329787.234042553
Net income: 5112765.957446809
Capital expenditures: 0
Depreciation & amortization: 13035106.382978724
Net tangible assets: 115242553.19148937
Owner earnings: 18147872.340425532
Return on net tangible assets (%): 15.74754449449819
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2966.5000000000005
P/E ratio: 43.51607365792759
Shares outstanding: 75000
Book value: 117104255.31914894
P/B ratio: 1.8999096095495924
Market cap (USD): 222487500.00000003
Debt to equity: 0.15366376569341741
Current ratio: 1.0737228352153803
Quick ratio: 0.7567379002041397
Effective tax rate (%): 26.581118240146655
Interest coverage ratio: 28.78676470588235
COGS to revenue (%): 54.42790946355374
Buyback yield (%): 0
Inventory turnover: 4.97913100187495
Receivables turnover: 8.22124542124542
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.093954299234169
Rule of 40 score: 0
Financial ratios for COBH.BR — annual report dated 2023-12-31
Total revenue: 132097777.77777778
Gross profit: 52642222.222222224
Operating income: -2404444.4444444445
Net income: -4893333.333333333
Capital expenditures: 0
Depreciation & amortization: 14231111.11111111
Net tangible assets: 115211111.1111111
Owner earnings: 9337777.777777776
Buffett classification: The Gruesome
Stock price: 2400
Shares outstanding: 75000
Book value: 117419999.99999999
P/B ratio: 1.532958610117527
Market cap (USD): 180000000
Debt to equity: 0.23730577792918112
Current ratio: 1.1742943272129351
Quick ratio: 0.7928747602082763
Interest coverage ratio: -2.9203778677462893
COGS to revenue (%): 60.149047843348356
Buyback yield (%): 0
Inventory turnover: 5.137950855007904
Receivables turnover: 8.140225950017117
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.599408721359941
Revenue growth (%): 10.650428721360814
Rule of 40 score: 10.650428721360814
Financial ratios for COBH.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 104642708.33333334
Buffett classification: The Gruesome
Stock price: 1583.3333333333335
Shares outstanding: 75000
Book value: 106597916.66666666
P/B ratio: 1.1139992573338287
Market cap (USD): 118750000.00000001
Debt to equity: 0.2758711669630817
Current ratio: 1.0994525547445255
Quick ratio: 0.7701251303441086
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COBH.BR — annual report dated 2024-12-31
Total revenue: 116775000
Gross profit: 46022916.66666667
Operating income: -4457291.666666667
Net income: -8522916.666666668
Capital expenditures: 0
Depreciation & amortization: 13471875
Net tangible assets: 104642708.33333334
Owner earnings: 4948958.333333332
Buffett classification: The Gruesome
Stock price: 1583.3333333333335
Shares outstanding: 75000
Book value: 106597916.66666666
P/B ratio: 1.1139992573338287
Market cap (USD): 118750000.00000001
Debt to equity: 0.2758711669630817
Current ratio: 1.0994525547445255
Quick ratio: 0.7701251303441086
Interest coverage ratio: -3.16962962962963
COGS to revenue (%): 60.588382216513246
Buyback yield (%): 0
Inventory turnover: 5.376553471067839
Receivables turnover: 6.501043841336117
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.240390149335111
Revenue growth (%): -11.59957270708566
Rule of 40 score: -11.59957270708566
Financial ratios for CP8.AX — annual report dated 2021-12-31
Capital expenditures: 330794.92753623193
Buffett classification: The Gruesome
Stock price: 0.1811594202898551
Shares outstanding: 388486575
Market cap (USD): 70378002.71739131
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CP8.AX — annual report dated 2022-12-31
Total revenue: 2403247.972972973
Gross profit: 109606.75675675676
Operating income: -2872237.1621621624
Net income: -2848101.3513513515
Capital expenditures: 236603.37837837837
Depreciation & amortization: 56055.40540540541
Net tangible assets: 9169797.972972972
Owner earnings: -3028649.3243243243
Return on net tangible assets (%): -33.02852836290345
Buffett classification: The Gruesome
Stock price: 0.11486486486486487
Shares outstanding: 388486575
Book value: 9169797.972972972
P/B ratio: 4.866351262122917
Market cap (USD): 44623457.93918919
Debt to equity: 0.04263791658588959
Current ratio: 4.715968807736743
Quick ratio: 3.746414296348628
COGS to revenue (%): 95.43922400062755
SG&A to revenue (%): 64.01320060379999
Free cash flow (dilution-adjusted): -5183746.621621622
Buyback yield (%): 0.458866640145196
Retained earnings: -16391690.54054054
Inventory turnover: 2.7667678690047803
Receivables turnover: 2.125885933486104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.349433458241492
FCF margin (%): -215.69753433346256
Rule of 40 score: -215.69753433346256
Financial ratios for CP8.AX — annual report dated 2023-12-31
Total revenue: 1908125.3424657534
Gross profit: 431616.4383561644
Operating income: -2774089.0410958906
Net income: -3065135.616438356
Capital expenditures: 776208.2191780822
Depreciation & amortization: 149374.65753424657
Net tangible assets: 7353957.534246575
Owner earnings: -3691969.1780821923
Return on net tangible assets (%): -50.20384141313158
Buffett classification: The Gruesome
Stock price: 0.03424657534246576
Shares outstanding: 388486575
Book value: 7353957.534246576
P/B ratio: 1.8091394597150094
Market cap (USD): 13304334.760273974
Debt to equity: 0.10961407602914021
Current ratio: 2.7764785770361415
Quick ratio: 2.0452058824091215
COGS to revenue (%): 77.38007935063568
SG&A to revenue (%): 77.51389784781233
Free cash flow (dilution-adjusted): -1967965.0684931506
Buyback yield (%): 0.3414172034130137
Retained earnings: -19681369.8630137
Inventory turnover: 2.8154024777910407
Receivables turnover: 6.359677297848881
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.52648568158517
FCF margin (%): -103.1360479679008
Revenue growth (%): -20.6022281543723
Rule of 40 score: -123.73827612227309
Financial ratios for CP8.AX — annual report dated 2024-12-31
Total revenue: 1548959.6273291924
Gross profit: 767252.1739130435
Operating income: -962658.3850931677
Net income: -1033675.1552795031
Capital expenditures: 8459.006211180124
Depreciation & amortization: 181857.76397515528
Net tangible assets: 6435114.285714285
Owner earnings: -860276.3975155279
Return on net tangible assets (%): -13.368471161814632
Buffett classification: The Gruesome
Stock price: 0.018633540372670804
Shares outstanding: 388486575
Book value: 6435114.285714285
P/B ratio: 1.1249031420581215
Market cap (USD): 7238880.279503104
Debt to equity: 0.08647527241356479
Current ratio: 2.2302499890018037
Quick ratio: 1.5932495820685408
COGS to revenue (%): 50.466612532956404
SG&A to revenue (%): 43.1987408899983
Free cash flow (dilution-adjusted): -1088498.1366459627
Buyback yield (%): 0.44706821593513246
Retained earnings: -18881377.01863354
Inventory turnover: 2.716200962989021
Receivables turnover: 8.309038629412196
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.321409698045272
FCF margin (%): -70.27285394925467
Revenue growth (%): -18.82296236747389
Rule of 40 score: -89.09581631672856
Financial ratios for CP8.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 6435114.285714285
Buffett classification: The Gruesome
Stock price: 0.018633540372670804
Shares outstanding: 388486575
Book value: 6435114.285714285
P/B ratio: 1.1249031420581215
Market cap (USD): 7238880.279503104
Debt to equity: 0.08647527241356479
Current ratio: 2.2302499890018037
Quick ratio: 1.5932495820685408
Buyback yield (%): 0
Retained earnings: -18881377.01863354
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEME.BR — annual report dated 2022-12-31
Total revenue: 2824175531.9148936
Gross profit: 1010752127.6595745
Operating income: 152056382.9787234
Net income: 122756382.9787234
Capital expenditures: 503709574.4680851
Operating cash flow: 464222340.4255319
Depreciation & amortization: 338553191.4893617
Net tangible assets: 1826174468.0851064
Owner earnings: -42400000
Return on net tangible assets (%): -2.3217934945974728
Capex to operating income (%): 331.26499828591017
Buffett classification: The Gruesome
Stock price: 122.32978723404256
P/E ratio: 25.110415458571293
Shares outstanding: 25197982
Book value: 1889643617.021277
P/B ratio: 1.6312408059495624
Market cap (USD): 3082463776.7872343
Debt to equity: 0.5870604892851009
Current ratio: 0.8966481243593766
Quick ratio: 0.8816916591048123
Effective tax rate (%): 23.953408439946532
Interest coverage ratio: 9.583813866166018
COGS to revenue (%): 64.21071862433962
Free cash flow (dilution-adjusted): -50588297.872340426
Buyback yield (%): 0
Retained earnings: 1296034042.5531917
Inventory turnover: 66.33787359900374
Receivables turnover: 6.4519951003504605
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.11988107711182
FCF margin (%): -1.7912589816270987
Rule of 40 score: -1.7912589816270987
Financial ratios for DEME.BR — annual report dated 2023-12-31
Total revenue: 3650468888.888889
Gross profit: 1273844444.4444444
Operating income: 259373333.3333333
Net income: 190658888.8888889
Capital expenditures: 380413333.3333333
Operating cash flow: 504064444.4444444
Depreciation & amortization: 380055555.5555555
Net tangible assets: 2082894444.4444444
Owner earnings: 190301111.1111111
Return on net tangible assets (%): 9.136378063645408
Capex to operating income (%): 146.6663239603146
Buffett classification: The Gruesome
Stock price: 116.17777777777778
P/E ratio: 15.35436176254276
Shares outstanding: 25197982
Book value: 2178677777.7777777
P/B ratio: 1.3436799067324219
Market cap (USD): 2927445553.2444444
Debt to equity: 0.45963963872073277
Current ratio: 0.8421994529327076
Quick ratio: 0.8258948919845118
Effective tax rate (%): 22.76117691312605
Interest coverage ratio: 11.828527995946288
COGS to revenue (%): 65.10463496013601
Free cash flow (dilution-adjusted): 60790000
Buyback yield (%): 0
Retained earnings: 1568612222.222222
Inventory turnover: 66.81124472903325
Receivables turnover: 7.334841043043401
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.34744324774888
FCF margin (%): 1.6652655275334494
Revenue growth (%): 29.257861192988184
Rule of 40 score: 30.923126720521633
Financial ratios for DEME.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2176851041.666667
Buffett classification: The Gruesome
Stock price: 136.44791666666669
Shares outstanding: 25197982
Book value: 2264656250.0000005
P/B ratio: 1.5182048702111708
Market cap (USD): 3438212148.104167
Debt to equity: 0.35064418348995197
Current ratio: 0.924172362151754
Quick ratio: 0.9162788793725993
Buyback yield (%): 0
Retained earnings: 1708395833.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEME.BR — annual report dated 2024-12-31
Total revenue: 4272040625
Gross profit: 1474595833.3333335
Operating income: 373103125
Net income: 308096875
Capital expenditures: 285932291.6666667
Operating cash flow: 1122309375
Depreciation & amortization: 412322916.6666667
Net tangible assets: 2176851041.666667
Owner earnings: 434487500.00000006
Return on net tangible assets (%): 19.959450218851103
Capex to operating income (%): 76.63626287414952
Buffett classification: The Gruesome
Stock price: 136.44791666666669
P/E ratio: 11.15951646086695
Shares outstanding: 25197982
Book value: 2264656250.0000005
P/B ratio: 1.5182048702111708
Market cap (USD): 3438212148.104167
Debt to equity: 0.35064418348995197
Current ratio: 0.924172362151754
Quick ratio: 0.9162788793725993
Effective tax rate (%): 25.95735428414049
Interest coverage ratio: 21.1140650789908
COGS to revenue (%): 65.4826355183986
Free cash flow (dilution-adjusted): 822833333.3333334
Buyback yield (%): 0.21846989102970735
Retained earnings: 1708395833.3333335
Inventory turnover: 131.38683953033268
Receivables turnover: 6.131079826524526
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.410342835898414
FCF margin (%): 19.260896736751736
Revenue growth (%): 17.02717527611369
Rule of 40 score: 36.28807201286543
Financial ratios for DEME.BR — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 134.32608695652172
Shares outstanding: 25197982
Market cap (USD): 3384746321.260869
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEME.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2523440000
Buffett classification: The Gruesome
Stock price: 147.9294117647059
Shares outstanding: 25197982
Book value: 2623976470.588236
P/B ratio: 1.4205625304566933
Market cap (USD): 3727522654.9176474
Debt to equity: 0.5055743864274248
Current ratio: 0.8519246256187192
Quick ratio: 0.8447999975113186
Buyback yield (%): 0
Retained earnings: 2023222352.9411764
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEME.BR — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 142.64705882352942
Shares outstanding: 25197982
Market cap (USD): 3594418020.5882354
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFP — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.5
Shares outstanding: 20538137
Market cap (USD): 400493671.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFP — annual report dated 2022-11-30
Total revenue: -85184878
Net income: -86485302
Capital expenditures: 0
Operating cash flow: 24552228
Net tangible assets: 428447593
Owner earnings: -86485302
Return on net tangible assets (%): -20.185736461822064
Buffett classification: The Gruesome
Stock price: 14.99
Shares outstanding: 20538137
Book value: 428447593
P/B ratio: 0.718563200400568
Market cap (USD): 307866673.63
Debt to equity: 0.6448863396928921
Free cash flow (dilution-adjusted): 24552228
Buyback yield (%): 0
Retained earnings: -66133724
Receivables turnover: -11.342169724159263
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFP — annual report dated 2023-11-30
Total revenue: 10171256
Net income: 8955797
Capital expenditures: 0
Operating cash flow: 32839839
Net tangible assets: 404558801
Owner earnings: 8955797
Return on net tangible assets (%): 2.2137194835121137
Buffett classification: The Gruesome
Stock price: 14.73
P/E ratio: 33.77999278121199
Shares outstanding: 20538137
Book value: 404558801
P/B ratio: 0.7477942817266754
Market cap (USD): 302526758.01
Debt to equity: 0.6829662321448298
COGS to revenue (%): 0
SG&A to revenue (%): 8.74912596831699
Free cash flow (dilution-adjusted): 32839839
Buyback yield (%): 0
Retained earnings: -90053081
Receivables turnover: 1.472329983532785
Capitalized R&D asset: 0
FCF margin (%): 322.86906356501106
Rule of 40 score: 322.86906356501106
Financial ratios for DFP — annual report dated 2024-11-30
Total revenue: 83133776
Net income: 81658941
Capital expenditures: 0
Operating cash flow: 26976549
Net tangible assets: 459224469
Owner earnings: 81658941
Return on net tangible assets (%): 17.78192289662161
Buffett classification: The Gruesome
Stock price: 18.36
P/E ratio: 4.617745352832827
Shares outstanding: 20538137
Book value: 459224469
P/B ratio: 0.8211239182030606
Market cap (USD): 377080195.32
Debt to equity: 0.6016665457780735
COGS to revenue (%): 0
SG&A to revenue (%): 1.3501167082799173
Free cash flow (dilution-adjusted): 26976549
Buyback yield (%): 0
Retained earnings: -35285585
Receivables turnover: 11.6753066752953
Capitalized R&D asset: 0
FCF margin (%): 32.449565384832276
Revenue growth (%): 717.3403166727885
Rule of 40 score: 749.7898820576207
Financial ratios for DFP — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 459224469
Buffett classification: The Gruesome
Stock price: 18.36
Shares outstanding: 20538137
Book value: 459224469
P/B ratio: 0.8211239182030606
Market cap (USD): 377080195.32
Debt to equity: 0.6016665457780735
Buyback yield (%): 0
Retained earnings: -35285585
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFP — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 448881562
Buffett classification: The Gruesome
Stock price: 18.5
Shares outstanding: 20538137
Book value: 448881562
P/B ratio: 0.8464494126403882
Market cap (USD): 379955534.5
Debt to equity: 0.6155298488290325
Buyback yield (%): 0
Retained earnings: -45628492
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHARMAJ.NS — annual report dated 2023-03-31
Total revenue: 63635809.98781974
Gross profit: 11022168.08769793
Operating income: 5330207.064555421
Net income: 3271619.9756394643
Capital expenditures: 8400730.816077955
Operating cash flow: -2888672.3507917174
Depreciation & amortization: 618879.4153471377
Net tangible assets: 38022898.903775886
Owner earnings: -4510231.425091353
Return on net tangible assets (%): -11.86188206350427
Capex to operating income (%): 157.60608761225748
Buffett classification: The Gruesome
Stock price: 1.7637028014616325
P/E ratio: 18.21983790320179
Shares outstanding: 33797296
Book value: 38389524.96954933
P/B ratio: 1.5527252729568692
Market cap (USD): 59608385.63702802
Debt to equity: 0.1663060238976071
Current ratio: 3.4807643649770474
Quick ratio: 2.6029254069424197
Effective tax rate (%): 29.726335618230337
Interest coverage ratio: 20.073853211009173
COGS to revenue (%): 82.67929945449325
SG&A to revenue (%): 2.015312470092832
Free cash flow (dilution-adjusted): -11307308.160779538
Buyback yield (%): 0
Retained earnings: 10576979.293544458
Inventory turnover: 5.9287655439347775
Receivables turnover: 7.185394031082383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.529203600632172
FCF margin (%): -17.76878170159824
Revenue growth (%): 23.17216194687101
Rule of 40 score: 5.403380245272771
Financial ratios for DHARMAJ.NS — annual report dated 2024-03-31
Total revenue: 78265979.13418876
Gross profit: 15688811.608106488
Operating income: 7143902.146540352
Net income: 5321501.379062237
Capital expenditures: 22757764.719990406
Operating cash flow: 885597.7935004197
Depreciation & amortization: 651876.7238277971
Net tangible assets: 42607147.13994484
Owner earnings: -16784386.617100373
Return on net tangible assets (%): -39.39335943326926
Capex to operating income (%): 318.56210028032837
Buffett classification: The Gruesome
Stock price: 2.6859404990403073
P/E ratio: 17.05863056648309
Shares outstanding: 33797296
Book value: 43094735.57980574
P/B ratio: 2.1064643943886145
Market cap (USD): 90777526.08445299
Debt to equity: 0.31134466993352194
Current ratio: 1.9433632119365947
Quick ratio: 1.2006505953185769
Effective tax rate (%): 22.808238241024213
Interest coverage ratio: 19.628665568369026
COGS to revenue (%): 79.95449391720038
SG&A to revenue (%): 1.9789783348144514
Free cash flow (dilution-adjusted): -21888235.999520324
Buyback yield (%): 0
Retained earnings: 15712435.543830195
Inventory turnover: 5.58813261656422
Receivables turnover: 5.499186909666928
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.615440873977235
FCF margin (%): -27.9664756534796
Revenue growth (%): 22.990465822890158
Rule of 40 score: -4.97600983058944
Financial ratios for DHARMAJ.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 46636526.5169613
Buffett classification: The Gruesome
Stock price: 4.058767319636885
Shares outstanding: 33797296
Book value: 47237338.74820831
P/B ratio: 2.9039603866781643
Market cap (USD): 137175360.49689442
Debt to equity: 0.3456991789537034
Current ratio: 1.4388115007613247
Quick ratio: 1.0923403597259231
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHARMAJ.NS — quarterly report dated 2024-12-31
Total revenue: 20341298.519640982
Gross profit: 4841473.365194079
Operating income: 563702.0631775265
Net income: 137428.6047324863
Capital expenditures: 0
Depreciation & amortization: 543070.2879123441
Owner earnings: 680498.8926448304
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.976454132183238
P/E ratio: 182.99702149279048
Shares outstanding: 33797296
Market cap (USD): 100596101.33582002
Effective tax rate (%): 23.391812865497073
Interest coverage ratio: 1.4834355828220858
COGS to revenue (%): 76.19879890893255
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHARMAJ.NS — annual report dated 2025-03-31
Total revenue: 111181201.77694646
Gross profit: 24161561.842412904
Operating income: 6605564.648117839
Net income: 4071194.762684124
Capital expenditures: 3515314.472761281
Operating cash flow: 4521861.117605798
Depreciation & amortization: 2136193.593640402
Net tangible assets: 45363923.31073182
Owner earnings: 2692073.8835632447
Return on net tangible assets (%): 5.934393868720733
Capex to operating income (%): 53.21747132946339
Buffett classification: The Good
Stock price: 2.116232932664255
P/E ratio: 17.5680494300516
Shares outstanding: 33797296
Book value: 46108253.44867898
P/B ratio: 1.5511962713966354
Market cap (USD): 71522950.8302019
Debt to equity: 0.2929819223650516
Current ratio: 1.5305871754975022
Quick ratio: 1.0150609361157228
Effective tax rate (%): 23.891426448412265
Interest coverage ratio: 4.381173916414671
COGS to revenue (%): 78.2683030438129
SG&A to revenue (%): 1.6020289282094202
Free cash flow (dilution-adjusted): 766892.6817862988
Buyback yield (%): 0
Retained earnings: 19414192.190787934
Inventory turnover: 5.37479421194004
Receivables turnover: 3.8288028599954913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.157358877040785
FCF margin (%): 0.6897682967349564
Revenue growth (%): 42.05559427848442
Rule of 40 score: 42.745362575219374
Financial ratios for DHARMAJ.NS — quarterly report dated 2025-03-31
Total revenue: 24541501.05213935
Gross profit: 4051437.923778349
Operating income: -86158.52232873508
Net income: -286883.32943652093
Capital expenditures: 0
Depreciation & amortization: 535305.1204115034
Net tangible assets: 45363923.31073182
Owner earnings: 248421.79097498243
Buffett classification: The Gruesome
Stock price: 2.116232932664255
Shares outstanding: 33797296
Book value: 46108253.44867898
P/B ratio: 1.5511962713966354
Market cap (USD): 71522950.8302019
Debt to equity: 0.2929819223650516
Current ratio: 1.5305871754975022
Quick ratio: 1.0150609361157228
Interest coverage ratio: -0.18573588709677416
COGS to revenue (%): 83.49148279410082
Buyback yield (%): 0
Retained earnings: 19414192.190787934
Inventory turnover: 1.2655749068538253
Receivables turnover: 0.8451479918837966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.15857237527217646
Revenue growth (%): 20.64864506286445
Rule of 40 score: 20.64864506286445
Financial ratios for DHARMAJ.NS — quarterly report dated 2025-06-30
Total revenue: 42988883.68827522
Gross profit: 10386145.565176692
Operating income: 5391060.145097122
Net income: 3813128.9492160077
Capital expenditures: 0
Depreciation & amortization: 544933.3021296513
Owner earnings: 4358062.251345659
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.7311022700678684
P/E ratio: 34.419317903341486
Shares outstanding: 33797296
Market cap (USD): 126101167.82775569
Effective tax rate (%): 25.476250371623937
Interest coverage ratio: 14.780879050368945
COGS to revenue (%): 75.83992726936194
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 75.16811052813642
Rule of 40 score: 75.16811052813642
Financial ratios for DHARMAJ.NS — quarterly report dated 2025-09-30
Total revenue: 39150281.84892897
Gross profit: 8529086.809470125
Operating income: 3045208.568207441
Net income: 1954227.733934611
Capital expenditures: 0
Depreciation & amortization: 539458.8500563698
Net tangible assets: 49149267.19278467
Owner earnings: 2493686.583990981
Return on net tangible assets (%): 5.073700436284563
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.3979706877113864
P/E ratio: 20.44219033748686
Shares outstanding: 33797296
Book value: 50092333.709131904
P/B ratio: 2.2926107176150468
Market cap (USD): 114842221.13190529
Debt to equity: 0.312556969204558
Current ratio: 1.4142789746815536
Quick ratio: 1.0427066250308898
Effective tax rate (%): 23.11036195883605
Interest coverage ratio: 5.9984454807905845
COGS to revenue (%): 78.21449448976712
Buyback yield (%): 0
Inventory turnover: 1.6421601228551734
Receivables turnover: 0.7704081179894932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.28852837118965
Revenue growth (%): -8.929289411609414
Rule of 40 score: -8.929289411609414
Financial ratios for DHARMAJ.NS — quarterly report dated 2025-12-31
Total revenue: 21113957.892391667
Gross profit: 4843043.332962015
Operating income: 272474.1004790019
Net income: 84215.21666481007
Capital expenditures: 0
Depreciation & amortization: 543277.2641194164
Owner earnings: 627492.4807842264
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6837473543500057
P/E ratio: 16.299816706185936
Shares outstanding: 33797296
Market cap (USD): 90703403.72418404
Effective tax rate (%): 22.302158273381295
Interest coverage ratio: 0.5269280482550625
COGS to revenue (%): 77.06236150680597
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -46.06946132887348
Rule of 40 score: -46.06946132887348
Financial ratios for DSGN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.41
Shares outstanding: 62456974
Market cap (USD): 1337203813.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSGN — annual report dated 2022-12-31
Total revenue: 0
Operating income: -67593000
Net income: -63308000
Capital expenditures: 918000
Operating cash flow: -51317000
Depreciation & amortization: 406000
Net tangible assets: 327310000
Owner earnings: -63820000
Return on net tangible assets (%): -19.49833491185726
Buffett classification: The Gruesome
Stock price: 10.26
Shares outstanding: 62456974
Book value: 327310000
P/B ratio: 1.9578031628731172
Market cap (USD): 640808553.24
Debt to equity: 0.011276771256606886
Current ratio: 31.098645137342242
Quick ratio: 31.098645137342242
Free cash flow (dilution-adjusted): -63160000
Buyback yield (%): 0
Retained earnings: -110764000
Receivables turnover: 0
Capitalized R&D asset: 48613000
ROCI (R&D-adjusted, %): -9.284102163560913
Rule of 40 score: 0
Financial ratios for DSGN — annual report dated 2023-12-31
Total revenue: 0
Operating income: -78190000
Net income: -66862000
Capital expenditures: 256000
Operating cash flow: -58560000
Depreciation & amortization: 537000
Net tangible assets: 277687000
Owner earnings: -66581000
Return on net tangible assets (%): -23.97699568218894
Buffett classification: The Gruesome
Stock price: 2.65
Shares outstanding: 62456974
Book value: 277687000
P/B ratio: 0.5960343159744604
Market cap (USD): 165510981.1
Debt to equity: 0.010983589437028022
Current ratio: 29.57638744543754
Quick ratio: 29.57638744543754
Free cash flow (dilution-adjusted): -71904000
Buyback yield (%): 0
Retained earnings: -177626000
Receivables turnover: 0
Capitalized R&D asset: 89633710
ROCI (R&D-adjusted, %): -15.24458685602392
Rule of 40 score: 0
Financial ratios for DSGN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.38
Shares outstanding: 62456974
Market cap (USD): 336018520.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSGN — annual report dated 2024-12-31
Total revenue: 0
Operating income: -62383000
Net income: -49588000
Capital expenditures: 340000
Operating cash flow: -43105000
Depreciation & amortization: 596000
Net tangible assets: 242097000
Owner earnings: -49332000
Return on net tangible assets (%): -20.376956343944784
Buffett classification: The Gruesome
Stock price: 6.17
Shares outstanding: 62456974
Book value: 242097000
P/B ratio: 1.5917567321362924
Market cap (USD): 385359529.58
Debt to equity: 0.009640763826069716
Current ratio: 29.3122193334909
Quick ratio: 29.3122193334909
Free cash flow (dilution-adjusted): -56517000
Buyback yield (%): 0
Retained earnings: -227214000
Receivables turnover: 0
Capitalized R&D asset: 98624500
ROCI (R&D-adjusted, %): -19.880372022266013
Rule of 40 score: 0
Financial ratios for DSGN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.17
Shares outstanding: 62456974
Market cap (USD): 385359529.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSGN — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -20418000
Net income: -17715000
Capital expenditures: 72000
Operating cash flow: -16789000
Depreciation & amortization: 159000
Net tangible assets: 227919000
Owner earnings: -17628000
Return on net tangible assets (%): -7.734326668684928
Buffett classification: The Gruesome
Stock price: 3.86
Shares outstanding: 62456974
Book value: 227919000
P/B ratio: 1.0577613961100214
Market cap (USD): 241083919.64
Debt to equity: 0.009393688108494684
Current ratio: 28.36862554638174
Quick ratio: 28.36862554638174
Free cash flow (dilution-adjusted): -20400000
Buyback yield (%): 0
Retained earnings: -244929000
Receivables turnover: 0
Capitalized R&D asset: 15377000
ROCI (R&D-adjusted, %): -4.156174030589441
Rule of 40 score: 0
Financial ratios for DSGN — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -21569000
Net income: -19083000
Capital expenditures: 87000
Operating cash flow: -14441000
Depreciation & amortization: 152000
Net tangible assets: 213037000
Owner earnings: -19018000
Return on net tangible assets (%): -8.927087782873398
Buffett classification: The Gruesome
Stock price: 3.37
Shares outstanding: 62456974
Book value: 213037000
P/B ratio: 0.9879974012964884
Market cap (USD): 210480002.38
Debt to equity: 0.00913456347958336
Current ratio: 25.12792957585458
Quick ratio: 25.12792957585458
Free cash flow (dilution-adjusted): -18513000
Buyback yield (%): 0
Retained earnings: -264012000
Receivables turnover: 0
Capitalized R&D asset: 26040590
ROCI (R&D-adjusted, %): -6.746063088319314
Rule of 40 score: 0
Financial ratios for DSGN — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -19311000
Net income: -16997000
Capital expenditures: 0
Operating cash flow: -11162000
Depreciation & amortization: 155000
Net tangible assets: 199720000
Owner earnings: -16842000
Return on net tangible assets (%): -8.432805928299619
Buffett classification: The Gruesome
Stock price: 7.53
Shares outstanding: 62456974
Book value: 199720000
P/B ratio: 2.3548017936110552
Market cap (USD): 470301014.22
Debt to equity: 0.008727218105347486
Current ratio: 18.708404188669114
Quick ratio: 18.708404188669114
Free cash flow (dilution-adjusted): -14752000
Buyback yield (%): 0
Retained earnings: -281009000
Receivables turnover: 0
Capitalized R&D asset: 30207870
ROCI (R&D-adjusted, %): -8.6465535439814
Rule of 40 score: 0
Financial ratios for DSGN — annual report dated 2025-12-31
Total revenue: 0
Operating income: -79467000
Net income: -69792000
Capital expenditures: 193000
Operating cash flow: -54358000
Depreciation & amortization: 622000
Net tangible assets: 212503000
Owner earnings: -69363000
Return on net tangible assets (%): -32.640950951280686
Buffett classification: The Gruesome
Stock price: 9.38
Shares outstanding: 62456974
Book value: 212503000
P/B ratio: 2.756885390418018
Market cap (USD): 585846416.12
Debt to equity: 0.007223427433965638
Current ratio: 17.141631558789737
Quick ratio: 17.141631558789737
Free cash flow (dilution-adjusted): -69100000
Buyback yield (%): 0
Retained earnings: -297006000
Receivables turnover: 0
Capitalized R&D asset: 107674290
ROCI (R&D-adjusted, %): -23.01959754729012
Rule of 40 score: 0
Financial ratios for DSGN — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -18169000
Net income: -15997000
Capital expenditures: 34000
Operating cash flow: -11966000
Depreciation & amortization: 156000
Net tangible assets: 212503000
Owner earnings: -15875000
Return on net tangible assets (%): -7.470482769655017
Buffett classification: The Gruesome
Stock price: 9.38
Shares outstanding: 62456974
Book value: 212503000
P/B ratio: 2.756885390418018
Market cap (USD): 585846416.12
Debt to equity: 0.007223427433965638
Current ratio: 17.141631558789737
Quick ratio: 17.141631558789737
Free cash flow (dilution-adjusted): -15435000
Buyback yield (%): 0
Retained earnings: -297006000
Receivables turnover: 0
Capitalized R&D asset: 28393170
ROCI (R&D-adjusted, %): -8.001948487705016
Rule of 40 score: 0
Financial ratios for EXTR — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.16
Shares outstanding: 130778088
Market cap (USD): 1459483462.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXTR — annual report dated 2022-06-30
Total revenue: 1112321000
Gross profit: 629938000
Operating income: 72945000
Net income: 44271000
Capital expenditures: 15433000
Operating cash flow: 128177000
Depreciation & amortization: 40161000
Net tangible assets: -342316000
Owner earnings: 68999000
Return on net tangible assets (%): -20.15652204395938
Capex to operating income (%): 21.15703612310645
Buffett classification: The Great
Stock price: 8.92
P/E ratio: 26.349993109710645
Shares outstanding: 130778088
Book value: 90343000
P/B ratio: 12.912351205516753
Market cap (USD): 1166540544.96
Debt to equity: 3.886643126750274
Current ratio: 0.9778240277019719
Quick ratio: 0.8793976580477867
Effective tax rate (%): 15.179905736291527
Interest coverage ratio: 5.703729767769176
COGS to revenue (%): 43.36724740430146
R&D to revenue (%): 17.13453220787884
SG&A to revenue (%): 32.64947798342385
Free cash flow (dilution-adjusted): 69382000
Buyback yield (%): 3.855245340104496
Retained earnings: -934072000
Inventory turnover: 9.798358757693324
Receivables turnover: 6.042037621471289
Capitalized R&D asset: 190591000
ROCI (R&D-adjusted, %): 26.353985488149828
FCF margin (%): 6.237587890545984
Rule of 40 score: 6.237587890545984
Financial ratios for EXTR — annual report dated 2023-06-30
Total revenue: 1312454000
Gross profit: 754720000
Operating income: 111563000
Net income: 78074000
Capital expenditures: 13800000
Operating cash flow: 249212000
Depreciation & amortization: 34876000
Net tangible assets: -294066000
Owner earnings: 99150000
Return on net tangible assets (%): -33.71692069127339
Capex to operating income (%): 12.36969246076208
Buffett classification: The Great
Stock price: 26.05
P/E ratio: 43.635130676025305
Shares outstanding: 130778088
Book value: 116752000
P/B ratio: 29.179536045635192
Market cap (USD): 3406769192.4
Debt to equity: 2.2664194189392903
Current ratio: 1.0011416140024083
Quick ratio: 0.8464520478678578
Effective tax rate (%): 17.036108218392027
Interest coverage ratio: 6.417198734541271
COGS to revenue (%): 42.49550841400917
R&D to revenue (%): 16.32590551745052
SG&A to revenue (%): 32.52228268571699
Free cash flow (dilution-adjusted): 171940000
Buyback yield (%): 2.931222937637599
Retained earnings: -855998000
Inventory turnover: 6.264984723220705
Receivables turnover: 7.2095031448268285
Capitalized R&D asset: 341965970
ROCI (R&D-adjusted, %): 21.01797232668757
Rosenberg metric: 0.6547108730212864
FCF margin (%): 13.100649622767731
Revenue growth (%): 17.992378099487468
Rule of 40 score: 31.0930277222552
Financial ratios for EXTR — annual report dated 2024-06-30
Total revenue: 1117203000
Gross profit: 630831000
Operating income: -28881000
Net income: -85964000
Capital expenditures: 18121000
Operating cash flow: 55486000
Depreciation & amortization: 29447000
Net tangible assets: -379039000
Owner earnings: -74638000
Buffett classification: The Gruesome
Stock price: 13.45
Shares outstanding: 130778088
Book value: 25282000
P/B ratio: 69.57381866940906
Market cap (USD): 1758965283.6
Debt to equity: 9.477256546159323
Current ratio: 0.902119059947294
Quick ratio: 0.6296397907215778
Interest coverage ratio: -1.7002825856587778
COGS to revenue (%): 43.53479179701451
R&D to revenue (%): 18.96978436327149
SG&A to revenue (%): 39.89785204658419
Free cash flow (dilution-adjusted): -39398000
Buyback yield (%): 2.834336781108259
Retained earnings: -941962000
Inventory turnover: 3.448664132962732
Receivables turnover: 12.480205098415961
Capitalized R&D asset: 418386930
ROCI (R&D-adjusted, %): -2.390025684561081
Rosenberg metric: -0.5781910673449386
FCF margin (%): -3.5264853388327815
Revenue growth (%): -14.87678806266734
Rule of 40 score: -18.403273401500122
Financial ratios for EXTR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.03
Shares outstanding: 130778088
Market cap (USD): 1965594662.6399999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXTR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.74
Shares outstanding: 130778088
Market cap (USD): 2189225193.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXTR — quarterly report dated 2025-03-31
Total revenue: 284505000
Gross profit: 175409000
Operating income: 9936000
Net income: 3458000
Capital expenditures: 5742000
Operating cash flow: 29974000
Depreciation & amortization: 4562000
Net tangible assets: -329989000
Owner earnings: 2278000
Return on net tangible assets (%): -0.6903260411710693
Capex to operating income (%): 57.789855072463766
Buffett classification: The Good
Stock price: 13.23
P/E ratio: 125.08632910931175
Shares outstanding: 130778088
Book value: 71705000
P/B ratio: 24.129336925458475
Market cap (USD): 1730194104.24
Debt to equity: 3.170141552193013
Current ratio: 0.9309245608072474
Quick ratio: 0.7048570011055508
Effective tax rate (%): 51.75108134505372
Interest coverage ratio: 2.616802739004477
COGS to revenue (%): 38.345899017591954
R&D to revenue (%): 19.56239784889545
SG&A to revenue (%): 38.42111737930792
Free cash flow (dilution-adjusted): 3878000
Buyback yield (%): 0.751360784789539
Retained earnings: -941626000
Inventory turnover: 0.9426117610465016
Receivables turnover: 2.858025435477066
Capitalized R&D asset: 55656000
ROCI (R&D-adjusted, %): 7.626817732999768
FCF margin (%): 1.3630691903481487
Rule of 40 score: 1.3630691903481487
Financial ratios for EXTR — quarterly report dated 2025-06-30
Total revenue: 307003000
Gross profit: 189088000
Operating income: -1755000
Net income: -7803000
Capital expenditures: 6646000
Operating cash flow: 81939000
Depreciation & amortization: 4601000
Net tangible assets: -340531000
Owner earnings: -9848000
Buffett classification: The Gruesome
Stock price: 17.95
Shares outstanding: 130778088
Book value: 65584000
P/B ratio: 35.79328311173457
Market cap (USD): 2347466679.6
Debt to equity: 3.4069590143937547
Current ratio: 0.9105609185626196
Quick ratio: 0.7360714437593026
Interest coverage ratio: -0.4971671388101983
COGS to revenue (%): 38.408419461699076
R&D to revenue (%): 18.39363133259284
SG&A to revenue (%): 43.60185405354345
Free cash flow (dilution-adjusted): 54552000
Buyback yield (%): 1.064679648797346
Retained earnings: -949429000
Inventory turnover: 1.1495154906510168
Receivables turnover: 2.4229172585787797
Capitalized R&D asset: 93758520
ROCI (R&D-adjusted, %): 2.6307024750906356
Rosenberg metric: 0.2457776340376599
FCF margin (%): 17.769207467028007
Revenue growth (%): 7.907769634980053
Rule of 40 score: 25.67697710200806
Financial ratios for EXTR — annual report dated 2025-06-30
Total revenue: 1140067000
Gross profit: 709127000
Operating income: 18441000
Net income: -7467000
Capital expenditures: 24713000
Operating cash flow: 152031000
Depreciation & amortization: 19218000
Net tangible assets: -340531000
Owner earnings: -12962000
Capex to operating income (%): 134.01117076080473
Buffett classification: The Gruesome
Stock price: 17.95
Shares outstanding: 130778088
Book value: 65584000
P/B ratio: 35.79328311173457
Market cap (USD): 2347466679.6
Debt to equity: 3.4069590143937547
Current ratio: 0.9105609185626196
Quick ratio: 0.7360714437593026
Effective tax rate (%): 274.74842031359697
Interest coverage ratio: 1.1577724761426418
COGS to revenue (%): 37.799532834473766
R&D to revenue (%): 19.425086420359506
SG&A to revenue (%): 40.97864423757551
Free cash flow (dilution-adjusted): 45004000
Buyback yield (%): 1.6184681269458476
Retained earnings: -949429000
Inventory turnover: 4.201095751525668
Receivables turnover: 8.997592890740917
Capitalized R&D asset: 434161870
ROCI (R&D-adjusted, %): 2.402522894494085
Rosenberg metric: 0.3694409973057269
FCF margin (%): 3.9474872967992227
Revenue growth (%): 2.04653943822206
Rule of 40 score: 5.994026735021283
Financial ratios for EXTR — quarterly report dated 2025-09-30
Total revenue: 310245000
Gross profit: 188029000
Operating income: 11666000
Net income: 5611000
Capital expenditures: 6855000
Operating cash flow: -13998000
Depreciation & amortization: 4910000
Net tangible assets: -336499000
Owner earnings: 3666000
Return on net tangible assets (%): -1.0894534604857666
Capex to operating income (%): 58.760500600034284
Buffett classification: The Good
Stock price: 20.65
P/E ratio: 2133.149697630332
Shares outstanding: 130778088
Book value: 68563000
P/B ratio: 39.388117748639935
Market cap (USD): 2700567517.2
Debt to equity: 3.5352303720665663
Current ratio: 0.9106059346687724
Quick ratio: 0.7482943368520212
Effective tax rate (%): 32.81848659003831
Interest coverage ratio: 3.19353955652888
COGS to revenue (%): 39.3933826491966
R&D to revenue (%): 18.6152879176135
SG&A to revenue (%): 38.06991248851714
Free cash flow (dilution-adjusted): -42633000
Buyback yield (%): 0.4443510456069556
Retained earnings: -943818000
Inventory turnover: 1.3038737691101319
Receivables turnover: 2.1278660640187654
Capitalized R&D asset: 113953710
ROCI (R&D-adjusted, %): 1.8556239293591688
Rosenberg metric: -0.018753652446475057
FCF margin (%): -13.741720253348161
Revenue growth (%): 1.056015739259877
Rule of 40 score: -12.685704514088284
Financial ratios for EXTR — quarterly report dated 2025-12-31
Total revenue: 317925000
Gross profit: 195080000
Operating income: 13159000
Net income: 7876000
Capital expenditures: 7067000
Operating cash flow: 50138000
Depreciation & amortization: 4753000
Net tangible assets: -308620000
Owner earnings: 5562000
Return on net tangible assets (%): -1.8022163178018276
Capex to operating income (%): 53.70468880614029
Buffett classification: The Good
Stock price: 16.65
P/E ratio: 238.18148820826954
Shares outstanding: 130778088
Book value: 95912000
P/B ratio: 22.70263538660439
Market cap (USD): 2177455165.2
Debt to equity: 2.211641921761615
Current ratio: 0.9479529038719472
Quick ratio: 0.800037866589282
Effective tax rate (%): 24.29834678969627
Interest coverage ratio: 3.916369047619048
COGS to revenue (%): 38.63961626169694
R&D to revenue (%): 18.092946449634347
SG&A to revenue (%): 39.00039317449084
Free cash flow (dilution-adjusted): 20172000
Buyback yield (%): 0
Retained earnings: -935942000
Inventory turnover: 1.469560848396397
Receivables turnover: 2.0857525241591057
Capitalized R&D asset: 114851280
ROCI (R&D-adjusted, %): 1.86991400929052
Rosenberg metric: 0.12208889581493602
FCF margin (%): 6.344892663364001
Revenue growth (%): 2.4754629405792197
Rule of 40 score: 8.82035560394322
Financial ratios for HCG.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.5592773308716863
Shares outstanding: 149302203
Market cap (USD): 531407946.58710265
Buyback yield (%): 0
Retained earnings: -57569431.62336806
Capitalized R&D asset: 0
Rule of 40 score: 0